Human Kremen-1 Antibody, R&D Systems™

Kremen-1

Polyclonal

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

EC 3.4.21, FLJ31863, KREMEM1, KREMEN, kremen protein 1, Kremen1, kringle containing transmembrane protein, kringle containing transmembrane protein 1, Kringle domain-containing transmembrane protein 1, kringle-coding gene marking the eye and the nose, Kringle-containing protein marking the eye and the nose, KRM1, KRM1Dickkopf receptor

Goat

Affinity Purified

RUO

83999

Reconstitute at 0.2 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

Western Blot, Immunohistochemistry

LYOPH

Western Blot 0.1 ug/mL, Immunohistochemistry 5-15 ug/mL

NP_114434

KREMEN1

Mouse myeloma cell line NS0-derived recombinant mouse Kremen-1 Ala20-Gly397 Accession # NP_114434

25 μg

Primary

Detects human Kremen-1 in direct ELISAs and Western blots. In direct ELISAs, approximately 25% cross-reactivity with recombinant mouse Kremen-1 and less than 5% cross-reactivity with recombinant human Kremen-2 is observed.

Human

IgG